Drugs / IDP-118
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03058744 | Apr 2015 → Dec 2016 | psoriasis | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01670513 | Jun 2012 → May 2013 | psoriasis | Dow Pharmaceutical Sciences | Unknown | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT02785172 | Apr → Dec 2016 | psoriasis | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT02785159 | Feb → Nov 2016 | psoriasis | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02462122 | Aug 2015 → Nov 2016 | psoriasis | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT02462070 | Aug 2015 → Nov 2016 | psoriasis | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03988439 | Mar 2021 → Feb 2026 | psoriasis | Bausch Health Americas, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IDP-118 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02785172 ↗ |
| Route | Topical | “topical lotion” NCT02462070 ↗ |